Desoximetasone: Clinical Trials

6 trials of Desoximetasone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 unknown. 2 Phase 2, 2 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 32Completed 1, Unknown 1
Phase 42Completed 2

Follow Desoximetasone: new trials by email Literature Review of Desoximetasone trials Research Report on Desoximetasone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating Treatment Resistant Dermatitis TaroIIR
Phone calls, Desoximetasone 0.25% spray - Atopic Dermatitis, Psoriasis
Phase 4CompletedWake Forest University Health Sciences242017-02-012020-05-20
Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis
0.25% Desoximetasone cream (Topoxy®), 0.25% Desoximetasone cream (Topicorte®), Placebo - Scalp Psoriasis
Phase 3UnknownSiriraj Hospital1052016-01-012017-05-01
Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis
Topicort® (desoximetasone) Topical Spray, 0.25% - Plaque Psoriasis
Phase 4CompletedSun Pharmaceutical Industries, Inc.1292015-01-232023-03-28
Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis
Desoximetasone Spray 0.25%, placebo comparator - Psoriasis
Phase 3CompletedSun Pharmaceutical Industries, Inc.1202010-08-012017-06-05
Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis Study
Desoximetasone 0.25% spray - Psoriasis
Phase 2CompletedSun Pharmaceutical Industries, Inc.242010-02-012014-06-02
Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study
Desoximetasone 0.05% once daily, Desoximetasone 0.05% twice daily, Desoximetasone 0.25% once daily - Psoriasis
Phase 2CompletedSun Pharmaceutical Industries, Inc.1512009-11-012014-08-05

Conditions studied

Psoriasis (4)  ·  Dermatitis, Atopic (1)

Sponsors

Sun Pharmaceutical Industries, Inc. (4)  ·  Siriraj Hospital (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (4)  ·  Thailand (1)

Top investigators

Assist. Prof. Leena Chularojmontri, M.D. (1)  ·  Assist. Prof. Narumol Silpa-archa, M.D. (1)  ·  Associated. Prof. Chanisada Wongpraparut, M.D. (1)  ·  Pichanee Chaweekulrat, M.D. (1)  ·  Steve R Feldman, MD, PhD (1)

Results publications

PMID 28504031